The National Health Commission (NHSC) publishes the relevant notices to create exclusive, individual
Pharmaceutical and technological innovations continue to advance, and the National Health Commission of India represents new directions for industry-leading development. On July 10, the National Health Commission of India (NHC) issued a relevant notification, clearly identifying medical institutions with continuous reasonable use information interchangeability conditions, combining patient medical history with reasonable use programs, combining reasonable use monitoring data, different stages of clinical outcomes, distinguishing between taboo medicines, adapting drug dosage specifications, establishing an exclusive, personalized database of reasonable use medicines for each resident. At the same time, it is required to improve regional medical information platforms, unified medicines and clinical data standards, open pathways for cross-hospital logging of reasonable use of medicines, and ensure that continuous reasonable use management is implemented.
For example, patients with chronic illnesses often need to go to community health centers, comprehensive medical institutions, specialist outpatient clinics, but the logical dosages of medical institutions are independent of each other and cannot interact with each other, and patients can only rely on their own memories to recall past lists of medications, and it is easy to confuse the name of the medication, the dosage, and thus cause problems of repeated logical use and drug conflicts. The dynamically updated electronic rational use medicine file keeps the entire population's diagnosis, initiation of medication, review of all records, regardless of which level of medical institution the patient visits, the consulting physician can quickly coordinate the complete rational use trajectory, clearly check the drug allergies, previously rational use side effects, all types of rational use drug prohibitions. It can be predicted that with the advancement of technology and the upgrading of demand, this area will also open up new space for development.
This pioneering initiative to build an exclusive individualized database of rational use medication can accurately break the pain points of long-term use of patients. It is widely believed that regulation and specialization will be the key words for future developments. Based on complete data support, doctors will be able to target medication regimens, eliminate conflicting medications, streamline medication types, and reduce unreasonable use of medications from sources.
For special patients with periodic monitoring of hepatic function and blood concentrations, all types of testing and detection data will be synchronized into archives, continuously track the effectiveness of treatment and diagnosis, and will streamline personalized and rational drug services to the community and extend to the family. Based on the Unified Joint Regional Rational Medicines Data Platform, grassroots medical personnel are able to keep up-to-date with the overall medication status of the chronically ill residents in the jurisdiction, the system automatically delivers repeated risk hints such as rational medicines, drug packages, family doctors and basic public health service personnel can also routinely push up-to-the-door Rational Medicines Guidelines, Residential Pharmacy Cops. First, strictly adhere to the health data security baseline for residents, set up graded access permissions, properly protect the public's privacy of rational medicines, avoid the risk of information leakage.
In addition, to accommodate the challenges of digital operations in the elderly population, while maintaining paper logs of reasonable use of medicines online, arranging for healthcare personnel to assist with archival inquiries, providing parallel online services, and avoiding the use of digital services to older people. Second, to accelerate the upgrading of basic informational hardware, unify the standards for data collection across the region, break down barriers to data breaking across different medical platforms. Medicare beneficiaries are not a blanket slogan, but a real guarantee in every clinical detail in the field of pharmaceuticals, medicines, follow-up, etc.
Stable development, personalized patient-relevant drug archives, cross-agency data-sharing channels, continuous improvement of support for grassroots pharmaceutical services can be delivered to tens of millions of households. China's international healthcare system is constantly monitoring the latest developments in the field of healthcare, providing you with authority, reliable information and medical services. If you have further consultation needs on relevant content, please contact authoritative experts via the platform.
